Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis

Oncology

Volumn 81, Issue 3-4, 2011, Pages 175-183

  Kim, Hye Ryun ^a,b   Min, Byung Soh ^a   Kim, Jin Soo ^a   Shin, Sang Joon ^a,b   Ahn, Joong Bae ^a,b   Rho, Jae Kyung ^a,b   Kim, Nam Kyu ^a   Rha, Sun Young ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adjuvant chemotherapy; Colorectal neoplasms; Liver metastasis; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ALLERGY; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG EFFICACY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PRIMARY TUMOR; PRIORITY JOURNAL; RELAPSE FREE SURVIVAL; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80155135617     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000333440     Document Type: Article

References (22)

1. Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein WO, Encke A: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998; 228: 756-762.
2. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T: Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 2008; 371: 1007-1016.
3. Sharma S, Camci C, Jabbour N: Management of hepatic metastasis from colorectal cancers: An update. J Hepatobiliary Pancreat Surg 2008; 15: 570-580.
4. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, Nitti D, Torri V, Elias D, O'Callaghan C, Langer B, Martignoni G, Bouche O, Lazorthes F, Van Cutsem E, Bedenne L, Moore MJ, Rougier P: Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: A pooled analysis of two randomized trials. J Clin Oncol 2008; 26: 4906-4911.
5. Portier G, Elias D, Bouche O, Rougier P, Bosset J, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L: Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006; 24: 4976-4982.
6. Mihaylova Z, Raynov J: Neoadjuvant chemotherapy and targeted therapy in patients with liver metastases from colorectal cancer; medical oncologist's point of view. J BUON 2008; 13: 323-331.
7. Mandala M, Mosconi S, Quadri A, Milesi L, Labianca R: Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer. Expert Rev Anticancer Ther 2007; 7: 887-897.
8. Kemeny N: Management of liver metastases from colorectal cancer. Oncology (Williston Park) 2006; 20: 1161-1176, 1179, discussion 1179-1180, 1185-1186.
9. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D'Angelica M: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-4580.
10. Turrini O, Viret F, Guiramand J, Lelong B, Bege T, Delpero JR: Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol 2007; 33: 735-740.
11. Morris EJA, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G: Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010; 97: 1110-1118.
12. Robinson S, Manas DM, Pedley I, Mann D, White SA: Systemic chemotherapy and its implications for resection of colorectal liver metastasis. Surg Oncol 2011; 20: 57-72.
13. Lombardi L, Gebbia V, Silvestris N, Testa A, Colucci G, Maiello E: Adjuvant therapy in colon cancer. Oncology 2009; 77(suppl 1):50-56.
14. Alberts SR, Wagman LD: Chemotherapy for colorectal cancer liver metastases. Oncologist 2008; 13: 1063-1073.
15. Ychou M, Hohenberger W, Thezenas S, Navarro M, Maurel J, Bokemeyer C, Shacham-Shmueli E, Rivera F, Kwok-Keung Choi C, Santoro A: A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer. Ann Oncol 2009; 20: 1964-1970.
16. Lopez-Ladron A, Salvador AJ, Bernade R: Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer (abstract 1497). Proc Am Soc Clin Oncol 2003; 22: 373.
17. Nozawa H, Kitayama J, Sunami E, Saito S, Kanazawa T, Kazama S, Yazawa K, Kawai K, Mori K, Nagawa H: FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer. Oncology 2011; 80: 84-91.
18. Mentha G, Roth AD, Terraz S, Giostra E, Gervaz P, Andres A, Morel P, Rubbia-Brandt L, Majno PE: 'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg 2008; 25: 430-435.
19. Sawayama H, Hayashi N, Honda S, Baba Y, Toyama E, Watanabe M, Takamori H, Beppu T, Baba H: Treatment results of FOLFOX chemotherapy before surgery for lymph node metastasis of advanced colorectal cancer with synchronous liver metastasis: The status of LN metastasis and vessel invasions at the primary site in patients who responded to FOLFOX. Int J Clin Oncol 2010; 15: 70-76.
20. Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL: Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 2010; 17: 492-501.
21. Kanemitsu Y, Kato T, Shimizu Y, Inaba Y, Shimada Y, Nakamura K, Sato A, Moriya Y: A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603. Jpn J Clin Oncol 2009; 39: 406-409.
22. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB 3rd: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-an intergroup study. J Clin Oncol 200215; 20: 1499-1505.